Manulife (Manufacturers Life Insurance)’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.64M | Buy |
152,165
+9,578
| +7% | +$418K | 0.01% | 1036 |
|
|
2025
Q1 | $3.9M | Sell |
142,587
-4,709
| -3% | -$129K | ﹤0.01% | 1267 |
|
|
2024
Q4 | $5.93M | Buy |
147,296
+19,029
| +15% | +$766K | 0.01% | 1127 |
|
|
2024
Q3 | $6.07M | Sell |
128,267
-1,810
| -1% | -$85.7K | 0.01% | 1125 |
|
|
2024
Q2 | $3.88M | Buy |
130,077
+15,320
| +13% | +$457K | ﹤0.01% | 1273 |
|
|
2024
Q1 | $4.61M | Buy |
114,757
+14,684
| +15% | +$590K | ﹤0.01% | 1226 |
|
|
2023
Q4 | $2.55M | Buy |
100,073
+23,093
| +30% | +$588K | ﹤0.01% | 1396 |
|
|
2023
Q3 | $1.07M | Sell |
76,980
-4,410
| -5% | -$61.3K | ﹤0.01% | 1695 |
|
|
2023
Q2 | $1.87M | Buy |
81,390
+5,449
| +7% | +$125K | ﹤0.01% | 1431 |
|
|
2023
Q1 | $2.25M | Buy |
75,941
+10,955
| +17% | +$325K | ﹤0.01% | 1370 |
|
|
2022
Q4 | $1.66M | Sell |
64,986
-123
| -0.2% | -$3.13K | ﹤0.01% | 1435 |
|
|
2022
Q3 | $1.43M | Sell |
65,109
-716
| -1% | -$15.8K | ﹤0.01% | 1474 |
|
|
2022
Q2 | $1.33M | Buy |
65,825
+4,412
| +7% | +$88.9K | ﹤0.01% | 1527 |
|
|
2022
Q1 | $2.56M | Buy |
61,413
+43,674
| +246% | +$1.82M | ﹤0.01% | 1444 |
|
|
2021
Q4 | $1.12K | Buy |
17,739
+423
| +2% | +$27 | ﹤0.01% | 1761 |
|
|
2021
Q3 | $1.02M | Buy |
17,316
+1,151
| +7% | +$67.6K | ﹤0.01% | 1822 |
|
|
2021
Q2 | $784K | Buy |
16,165
+10,051
| +164% | +$487K | ﹤0.01% | 2132 |
|
|
2021
Q1 | $238K | Buy |
6,114
+49
| +0.8% | +$1.91K | ﹤0.01% | 2772 |
|
|
2020
Q4 | $376K | Buy |
+6,065
| New | +$376K | ﹤0.01% | 2382 |
|